Clinical Trials Logo
  1. Home
  2. Ewing's Sarcoma
  3. NCT00541411
  4. Details
NCT00541411 Clinical Trial

Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma

Ewing's Sarcoma Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT00541411
Other study ID # RAC#2031-065
Secondary ID
Status Active, not recruiting
Phase N/A
First received October 9, 2007
Last updated April 16, 2012
Start date June 2003
Est. completion date June 2013

Study information
Verified date April 2012
Source King Faisal Specialist Hospital & Research Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 10
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with Ewing's Sarcoma

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• Vincristine, Actinomycin-D, Ifosfamide
Chemotherapy

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
King Faisal Specialist Hospital & Research Center

Outcome
Type Measure Description Time frame Safety issue
Primary Efficacy overall No
See also
  Status Clinical Trial Phase
Withdrawn NCT01734863 - Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients Phase 3
Completed NCT01674101 - Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy N/A
Completed NCT02736565 - Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma Phase 1
Completed NCT00563680 - QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors Phase 2
Completed NCT00987636 - Study in Localized and Disseminated Ewing Sarcoma Phase 3
Terminated NCT00038142 - Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients Phase 2
Completed NCT02890758 - Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 Phase 1
Completed NCT01583543 - Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma Phase 2
Terminated NCT01313884 - Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Phase 2
Completed NCT01696669 - Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults Phase 2
Completed NCT00004853 - Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy Phase 1
Terminated NCT00568464 - Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) Phase 2
Completed NCT00001686 - Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
Completed NCT00492141 - Aerosol L9-NC and Temozolomide in Ewing's Sarcoma Phase 1/Phase 2
Completed NCT02063022 - Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma Phase 3
Completed NCT01598454 - Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides Phase 1
Recruiting NCT03442465 - Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Completed NCT02511132 - A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma Phase 2
Completed NCT00923650 - Informed Consent in Pediatric Cancer Trials N/A
Completed NCT01962103 - Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Phase 1/Phase 2